No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
Hi-CRATES CO.,LTD. specializes in the creation, sale, and maintenance of comprehensive electronic medical record systems tailored for dental practices. Beyond its core EMR offerings, the company also develops and supports applications for iPads and web platforms. Its extensive product portfolio features advanced solutions such as AI and voice-activated EMRs, tools for visual and periodontal examinations, medical interview software, self-pay estimation systems, and image management. Other notable products include systems for displaying customer information during calls, managing sub-clinical records, generating treatment proposals and quotes, facilitating oral X-ray examinations, cloud-based reservation management, online consultation services, digital patient registration, and automated payment and change dispensing machines. Established in 1978, the company is headquartered in Okayama, Japan. It was previously known as TOWA Hi SYSTEM CO.,LTD., undergoing a name change to Hi-CRATES CO.,LTD. in January 2026.
www.towa-hi-sys.co.jpNo one on the platform currently holds 4172.T.
No tracked institution reports a position in 4172.T as of their last filing.
No one on the platform has traded 4172.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 12.2% | 15.6% | — | — | — | |
| Rev. Growth % | 13.9% | 4.7% | ||||
| Profit Margin % | 18.6% | 16.1% | ||||
| Free Cash Flow Margin % | 17.5% | 10.2% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2.5B | +6.4% | $193.00 | $193.00–$193.00 | — | 1 |
| 2027 | $2.6B | +6.0% | $211.00 | $211.00–$211.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4172.THi-CRATES CO.,LTD. | $2300.00 | -2.42% | $5.1B | — |
| 206A.TPRISM BioLab Co.,LTD | $161.00 | -3.01% | $6.0B | — |
| 2796.TPharmarise Holdings Corporation | $505.00 | -0.39% | $5.8B | — |
| 4539.TNippon Chemiphar Co., Ltd. | $1550.00 | +0.00% | $5.6B | — |
| 4556.TKAINOS Laboratories, Inc. | $2268.00 | +0.00% | $10.1B | — |
| 4582.TSymBio Pharmaceuticals Limited | $56.00 | +0.00% | $3.1B |
Source: Financial Modeling Prep · peers by sector/industry
| — |
| 4892.TCyfuse Biomedical K.K. | $670.00 | +0.45% | $6.8B | — |